Steven Cohen Passage Bio, Inc. Transaction History

Point72 Asset Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.96 - $1.88 $85 - $167	89 New	89 $0
Q3 2021 Nov 15, 2021	SELL	$9.73 - $15.52 $1.82 Million - $2.91 Million	-187,500 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$12.44 - $19.45 $431,668 - $674,915	-34,700 Reduced 15.62%	187,500 $2.48 Million
Q1 2021 May 17, 2021	BUY	$16.24 - $29.83 $3.61 Million - $6.63 Million	222,200 New	222,200 $3.88 Million

38.7M

7.7K

Ticker PASG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,463,200
Market Cap $32.1M
Description
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.